Omicron Update: Three Times More Contagious, but Is It Actually a Milder Form of COVID-19?
The first major study of the effects of the Omicron variant of COVID-19 has been released by South Africa’s largest private health insurer, showing that while the variant seems to be causing milder symptoms in the country’s young people, vaccinations appear to be less effective against the new strain, a strain thatread more
Coronavirus Immunity May Last—and May Even Improve—for At Least Six-Months After Infection
There were concerns early in the COVID-19 pandemic that immunity to the disease caused by the SARS-CoV-2 coronavirus would be fleeting, due to the rapid decline in antibody levels documented in the months following the recovery of CODID-19 survivors. A new study out of Rockefeller University has confirmed that SARS-CoV-2read more
Pharmaceutical Factory Accidentally Produces Lemonade: Lower Doses of AstraZeneca Vaccine May Increase Effectiveness
Pharmaceutical company AstraZeneca has announced that a manufacturing error has caused what may be a fortunate discovery in regards to the COVID-19 vaccine they are producing, in that the drug may be much more effective at lower doses than anticipated. The Oxford University-developed inoculant is amongst a host of vaccine candidates thatread more